A former study has reported that BDNF and TrkB-TK+ were downregulated in the hippocampus of patients suffering from schizophrenia and mood disorders24, which was consistent with our results that APP/PS1 transgenic mice present BDNF/TrkB signaling deficits. The gene discussed is NTRK2; the disease is schizophrenia.